2012-08-19 18:00:21 - New Healthcare research report from GlobalData is now available from Fast Market Research

Santen Pharmaceutical Co., Ltd. (Santen) is a pharmaceutical company involved in the research, development, manufacture and commercialization of pharmaceuticals and medical devices. The company reports its business in two segments Pharmaceuticals and Other Business. The Pharmaceuticals segment includes prescription pharmaceuticals (prescription ophthalmic pharmaceuticals, prescription anti-rheumatic pharmaceuticals and other pharmaceuticals) and over the counter drugs. The major customers in this segment are Suzuken Co., Ltd., Mediceo Corporation and Toho Pharmaceutical Co., Ltd. The Other business includes manufacturing and selling of medical devices and others. The company operates its business through 13 subsidiaries. The company principally operates in Japan, with operations in the US, Asia Pacific and Europe. Santen is headquartered in Osaka, Japan.


Full Report Details at
- www.fastmr.com/prod/426306_santen_pharmaceutical_co_ltd_4536_fin ..


The company

aims at being recognized as specialty pharmaceutical company with global presence. To achieve this objective, the company focuses on promoting research and development operation (indicated from the the agreement with Ube Industries, Ltd. under which the company will develop Ube's EP2 agonist compound as an ophthalmic treatment drug); launch of new products (reflected from the recent launch of OTC eye drop Sante Medical Guard), strengthening its presence in other countries (indicated from the acquisition of Novagali Pharma SA and plans to establish Santen Holdings EU B.V., in Amsterdam, Netherlands).

Santen Pharmaceutical Co., Ltd. Key Recent Developments

Feb 07, 2012: Santen Pharmaceutical Reports Net Sales Of JPY86.4 Billion In Q3 Fiscal 2012

Feb 07, 2012: Santen To Establish New Company In Europe

Jan 23, 2012: Santen Launches Nutritional Supplement Sante Lutax 20 + DHA

Mar 01, 2012: Santen To Launch Sante Medical Guard OTC Eye Drop

Nov 01, 2011: Santen Pharmaceutical Reports Total Sales Of JPY56.79 Billion In Q2 Fiscal 2012

This comprehensive SWOT profile of Santen Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Santen Pharmaceutical Co., Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

* Business description - A detailed description of the company's operations and business divisions.
* Corporate strategy - Analyst's summarization of the company's business strategy.
* SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
* Company history - Progression of key events associated with the company.
* Major products and services - A list of major products, services and brands of the company.
* Key competitors - A list of key competitors to the company.
* Key employees - A list of the key executives of the company.
* Executive biographies - A brief summary of the executives' employment history.
* Key operational heads - A list of personnel heading key departments/functions.
* Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
* Key manufacturing facilities - A list of key manufacturing facilities of the company.
* Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
* Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

* The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

* The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

* Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.